The inside story from Aspen on Covid-19 Dexamethasone: MUST LISTEN

Loading player...
This week, the world woke up to the exciting news that Dexamethasone, a cheap drug in the Aspen stable, dramatically improves the chances of survival for people seriously ill in hospitals with Covid-19. The Aspen share price has jumped up in value on the Johannesburg stock exchange as investors anticipate high demand for Dexamethasone. In this interview with BizNews founder Alec Hogg, Aspen group senior executive Stavros Nicolaou shares the details of what is known about Dexamethasone and how it will be made available. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Jun 2020 2PM English South Africa Investing · Business News

Other recent episodes

Jabulani Khumalo - Threats, a R14-m ransom & the battle for MKP….

In his latest interview with Chris Steyn, the real founder of MKP, Jabulani Khumalo, reveals threats to the actual directors of the “hijacked” party over a picket to distance themselves from the human trafficking of 19 men to Russia. “…our spokesperson… got a call…a threatening call…And also, the people on…
11 Jan 6AM 18 min

Magnus Heystek: Why SA’s middle class is quietly being crushed

South Africans are being told everything is fine. Magnus Heystek says it’s a dangerous illusion. In a wide-ranging conversation with Alec Hogg, the veteran investment strategist warns that falling GDP per capita, rising taxes, weak property returns and flawed retirement structures are steadily hollowing out the middle class. From Regulation…
9 Jan 6AM 41 min